Till Sebastian Clauditz

Summary

Affiliation: University Medical Center Hamburg-Eppendorf
Country: Germany

Publications

  1. ncbi Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
    T S Clauditz
    Department of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Oral Pathol Med 42:125-32. 2013
  2. ncbi Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target
    Till Sebastian Clauditz
    Institute of Pathology, Hubertus Wald Cancer Center, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Oral Oncol 48:991-6. 2012
  3. ncbi Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
    Till Sebastian Clauditz
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Pathology 43:459-64. 2011
  4. ncbi 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma
    Till Sebastian Clauditz
    Department of Pathology, University Medical Center Hamburg Eppendorf, Martinistraße, Hamburg, Germany
    Diagn Mol Pathol 21:134-7. 2012

Collaborators

Detail Information

Publications4

  1. ncbi Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
    T S Clauditz
    Department of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    J Oral Pathol Med 42:125-32. 2013
    ..Analysis of IMP3 expression in head and neck squamous cell carcinomas (HNSCC) is rare so that we evaluated it using tissue microarray method...
  2. ncbi Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target
    Till Sebastian Clauditz
    Institute of Pathology, Hubertus Wald Cancer Center, University Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Oral Oncol 48:991-6. 2012
    ..To determine the potential applicability of EGFR targeted therapies, EGFR status of over 800 salivary gland tumors of different entities were analyzed on DNA and protein level by FISH and IHC...
  3. ncbi Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
    Till Sebastian Clauditz
    Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Pathology 43:459-64. 2011
    ..To determine the potential applicability of such therapies, salivary gland tumours were analysed for HER2 overexpression/amplification in this study...
  4. ncbi 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma
    Till Sebastian Clauditz
    Department of Pathology, University Medical Center Hamburg Eppendorf, Martinistraße, Hamburg, Germany
    Diagn Mol Pathol 21:134-7. 2012
    ..It is concluded that MECT1-MAML2 gene fusion is a highly specific genetic alteration in MEC with predominance in low-grade and intermediate-grade tumors...